Effects 0f Aliskiren on the Absorption of Monosaccharides in Animal Model of Fructose-induced Metabolic Syndrome
Author(s) -
Tavga Ahmed Aziz,
Zheen Orahman Ahmed,
Rbab Mohammed Utba,
Saad Abdulrahman Hussain
Publication year - 2018
Publication title -
al mustansiriyah journal of pharmaceutical sciences
Language(s) - English
Resource type - Journals
eISSN - 2959-183X
pISSN - 1815-0993
DOI - 10.32947/ajps.v17i2.45
Subject(s) - aliskiren , medicine , endocrinology , fructose , triglyceride , chemistry , monosaccharide , insulin , metabolic syndrome , adipose tissue , absorption (acoustics) , carbohydrate metabolism , cholesterol , renin–angiotensin system , diabetes mellitus , biochemistry , blood pressure , physics , acoustics
The renin angiotensin system (RAS) was involved in various metabolic processes including insulin secretion, carbohydrate absorption and proliferation of adipose tissue. This study aims to evaluate the effects of aliskiren on the absorption of glucose in rats with fructose-induced metabolic syndrome. The results showed that treatment with aliskiren attenuates the increase in body weight and improves fasting serum glucose, insulin, triglycerides and cholesterol levels. Moreover, absorption of glucose was significantly decreased after oral glucose load in high-fructose diet fed rats. In conclusion, aliskiren significantly reduces body weight, fasting serum glucose, insulin, triglyceride and total cholesterol levels, and the rate of glucose absorption after oral glucose load in high fructose-fed rats.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom